Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2014
05/30/2014WO2014079504A1 Polycyclic ligands of 5-ht7 receptor and use thereof
05/30/2014WO2014079398A1 Anti-hiv compound and preparation method and use thereof
05/30/2014WO2014079377A1 Antitumor prodrugs with function of p-glycoprotein inhibition
05/30/2014WO2014079364A1 Imidazolone derivatives, pharmaceutical compositions and uses thereof
05/30/2014WO2014079232A1 7-oxo-pyridopyrimidine derivatives, pharmaceutical compositions and uses thereof
05/30/2014WO2014079155A1 Use of benzo five-membered nitrogen heterocyclic piperazine or piperidine derivatives
05/30/2014WO2014079154A1 Benzo five-membered nitrogen heterocyclic piperidine or piperazine derivatives and preparation methods and pharmaceutical compositions thereof
05/30/2014WO2014079151A1 Use of statin compound in preparation of topical drug for treating obesity, diabetes, hypertension and hyperlipaemia
05/30/2014WO2014079150A1 Compounds and their methods of use
05/30/2014WO2014079136A1 Compounds, pharmaceutical compositions and uses as glutaminase inhibitors for treating cancers thereof
05/30/2014WO2014079070A1 Bis-β-carboline compound and preparation method, pharmaceutical composition and use thereof
05/30/2014WO2014079020A1 Pharmaceutical composition used for reducing damage caused by free radicals
05/30/2014WO2014079011A1 Heterocyclic compounds for inhibiting glutaminase and their methods of use
05/30/2014WO2014078971A1 Trpv-1 receptor antagonist compound derived from 1,3,4-thiadiazole alkylamides and chalcones
05/30/2014WO2014078968A1 Use of pkc412 in the reactivation of latent hiv-1
05/30/2014WO2014078957A1 Thienopyrimidine inhibitors of farnesyl and/or geranylgeranyl pyrophosphate synthase
05/30/2014WO2014078956A1 The use of bucillamine in the treatment of gout
05/30/2014WO2014078942A1 Compositions, uses and methods for treating or preventing dental caries
05/30/2014WO2014078898A1 Chemotherapy for drug-resistant cancer cells
05/30/2014WO2014078895A1 Omega-3 analogues
05/30/2014WO2014059199A8 Hemoglobin-based oxygen carrier-containing pharmaceutical composition for cancer targeting treatment and prevention of cancer recurrence
05/30/2014WO2014055972A3 A new chemical entity useful for treating various diseases
05/30/2014WO2014054005A3 Nanosomal preparation of the complex formed by quercetin (or another flavonol, flavone or a derivative thereof) and 2-hydroxypropyl-β-cyclodextrin for intravenous use in cerebral pathological conditions
05/30/2014WO2014053328A3 Pharmaceutical compositions
05/30/2014WO2014048564A8 "novel cross-linkers for hydrogels, hydrogels including these cross-linkers and applications thereof"
05/30/2014WO2014047569A9 Product comprising a nicotine-containing material and an anti-cancer agent
05/30/2014WO2014047519A3 Inhibitors of beta-hydrolase for treatment of cancer
05/30/2014WO2014043252A3 Hydroxypyridinone-,hydroxypyrimidinone-and hydroxypyridazinone drivatives and their therapeutic application
05/30/2014WO2014041560A3 Process for the preparation of teneligliptin
05/30/2014WO2014041559A3 Process for preparation of dabigatran etexilate and intermediates thereof
05/30/2014WO2014041558A3 Process for preparation of crystalline etoricoxib
05/30/2014WO2014041378A3 Topical pharmaceutical composition comprising tenofovir, an antibacterial agent and,optonally ciclopirox
05/30/2014WO2014033751A3 Pharmaceutical composition of propofol
05/30/2014WO2014031487A8 Bivalent inhibitors of iap proteins and therapeutic methods using the same
05/30/2014WO2014027975A3 Novel orally administered pharmaceutical formulations
05/30/2014WO2014022807A3 Compositions and methods of using the compositions for plaque softening
05/30/2014WO2014015067A4 Scirpusin a and scirpusin band anti-obesity potential thereof
05/30/2014WO2014011713A3 Anti-proliferative compounds and uses thereof
05/30/2014WO2013138418A3 Process for making cgrp receptor antagonists
05/30/2014WO2013106937A9 3' equatorial-fluorine-substituted neuraminidase inhibitor compounds, compositions and methods for the use thereof as anti-virals
05/30/2014WO2013075083A8 Modulators of methyl modifying enzymes, compositions and uses thereof
05/30/2014WO2013064520A8 Pesticidal compounds
05/30/2014WO2013059203A8 Novel modified curcumins and their uses
05/30/2014WO2013037479A8 Ophthalmic compositions comprising prostaglandin f2 alpha derivatives and hyaluronic acid
05/30/2014WO2012142511A3 Orthomolecular compositions and their use in stabilizing the extracellular matrix
05/30/2014WO2012027713A3 Compositions and methods for inhibition of snca
05/29/2014US20140148900 Device and method for intraocular drug delivery
05/29/2014US20140148513 Small molecule therapeutic compounds targeting thioesterase deficiency disorders and methods of using the same
05/29/2014US20140148512 Soap capable of treating seborrheic keratoses, keratosis pilaris, keratoderma, and related conditions and methods of making and using
05/29/2014US20140148511 Novel Uses of Neuraminidase Inhibitors in Infectious Diseases
05/29/2014US20140148509 Stabilized ascorbic acid solutions; method of use thereof; process for their obtention; and compositions comprising the same
05/29/2014US20140148507 Pharmaceutical composition and solid galenic form having a high dronedarone content, and method for preparing same
05/29/2014US20140148506 Drug elating silicone gel sheeting for wound healing and scar reduction
05/29/2014US20140148499 Methods and reagents for efficient control of hiv progression
05/29/2014US20140148498 Methods and compositions for the treatment of marfan syndrome and associated disorders
05/29/2014US20140148496 Therapeutic and Diagnostic Method for Ataxia-Telangiectasia
05/29/2014US20140148494 Spiro-oxindole mdm2 antagonists
05/29/2014US20140148491 Chemical Compositions And Methods For Enhancing Transdermal Delivery Of Therapeutic Agents
05/29/2014US20140148490 Bendamustine pharmaceutical compositions
05/29/2014US20140148488 Compositions and Methods for Modulating Metabolic Pathways
05/29/2014US20140148486 Sodium channel blocker delivery system with scleral lens
05/29/2014US20140148485 Novel formulations for treatment of migrane
05/29/2014US20140148483 Method For Predicting Effectiveness Of Angiogenesis Inhibitor
05/29/2014US20140148479 Treatment of Cognitive Disorders with (R)-7-Chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-Carboxamide and Pharmaceutically Acceptable Salts Thereof
05/29/2014US20140148478 Heteroquinoline-3-carboxamides as kcnq2/3 modulators
05/29/2014US20140148477 Animal ectoparasite-controlling agent and method for preventing or treating infection in animals caused by parasites by using the controlling agent
05/29/2014US20140148476 Methods for treating obesity and disorders associated with hyperlipidemia in a mammal
05/29/2014US20140148473 Use of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl)piperidine-2,6-dione in treatment of immune-related and inflammatory diseases
05/29/2014US20140148472 Gpr17-modulating compounds, diagnostic and therapeutic uses thereof
05/29/2014US20140148468 Specific carboxamides as kcnq2/3 modulators
05/29/2014US20140148465 Compositions and Methods to Improve Treatment of Medical Conditions Using D-Cycloserine
05/29/2014US20140148464 Salt forms of fatty acids for the treatment of dry eye
05/29/2014US20140148462 Indanyloxydihydrobenzofuranylacetic acids
05/29/2014US20140148460 Therapeutic compositions
05/29/2014US20140148459 Matrix metalloproteinase inhibitors
05/29/2014US20140148457 Thiazole derivatives
05/29/2014US20140148456 Preservative free brimonidine and timolol solutions
05/29/2014US20140148455 Preservative free bimatoprost and timolol solutions
05/29/2014US20140148454 Substituted amino-acrylcarboxamides as kcnq2/3 modulators
05/29/2014US20140148449 Highly loaded amorphous efavirenz composition and process for preparing the same
05/29/2014US20140148447 Agent for prophylactic and therapeutic treatment of herpes infections
05/29/2014US20140148446 Compounds that enable alternative mitochondrial electron transfer
05/29/2014US20140148442 Fast-dissolve dosage forms of 5-ht2c agonists
05/29/2014US20140148441 6-((s)-1--ethyl)-3h-1,3-benzothiazol-2-one as a tarp-gamma 8 dependent ampa receptor antagonist
05/29/2014US20140148439 Use of antioxidants for the treatment of cognitive and behavioural disorders in individuals with fragile x syndrome
05/29/2014US20140148438 Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
05/29/2014US20140148436 Akt protein kinase inhibitors
05/29/2014US20140148435 Azetidine and piperidine compounds useful as pde10 inhibitors
05/29/2014US20140148433 Bicyclic aza heterocycles, and use thereof
05/29/2014US20140148432 Compounds for the Treatment of Neurological Disorders
05/29/2014US20140148431 1,6- Diazabicyclo [3,2,1] octan-7-one derivatives and their use in the treatment of bacterial infections
05/29/2014US20140148429 Formulations of deoxycholic acid and salts thereof
05/29/2014US20140148427 Novel therapy for treatment of chronic degenerative brain diseases and nervous system injury
05/29/2014US20140148426 Use of a Clobetasol Spray Formulation to Treat Psoriasis
05/29/2014US20140148424 Pulmonary Pharmaceutical Formulations
05/29/2014US20140148423 Pharmaceutical composition comprising a trpa1 antagonist and a steroid
05/29/2014US20140148422 Treatment of glucose intolerance
05/29/2014US20140148421 Organic compounds
05/29/2014US20140148420 Combinations comprising antimuscarinic agents and pde4 inhibitors
05/29/2014US20140148419 Treatment of Excessive Menstrual Bleeding Associated with Uterine Fibroids
1 ... 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 ... 7860